Humoral Immunogenicity of 3 COVID-19 Messenger RNA Vaccine Doses in Patients With Inflammatory Bowel Disease

Trevor Schell, Keith L. Knutson, Sumona Saha, Arnold Wald, Hiep Phan, Mazen Almasry, Kelly Chun, Ian Grimes, Megan Lutz, Mary S. Hayney,

Inflammatory Bowel Diseases · 2022 · 32 citations · 19 references

DOIFull text

Open access

Concepts

Abstract

Lay Summary Herein, we evaluated the humoral immunogenicity of a third coronavirus disease 2019 messenger RNA vaccine dose in patients with inflammatory bowel diseases. All patients displayed a humoral immune response, and median antibody concentrations were higher after the third dose than after completion of the 2-dose series.

References

19